New 3D scanner could revolutionize how doctors measure kaposi sarcoma

NCT ID NCT06898203

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 4 times

Summary

This study will test a new 3D imaging device called SkinScan3D to see if it can measure Kaposi Sarcoma skin lesions more accurately and consistently than the current manual method. Researchers will compare the two methods in 300 adults with confirmed Kaposi Sarcoma who are starting or already on treatment. The goal is to see if the device is practical and easy to use in everyday clinic settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KAPOSI SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kaposi's sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KAPOSI SARCOMA

Contacts and locations

Locations

Infectious Diseases Institute, Makerere University
RECRUITING

Kampala, Uganda
Kenya Medical Research Institute
NOT_YET_RECRUITING

Kisumu, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.